Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Girolamo Pelaia

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Biomarkers in Medicine|April 4, 2013
Exhaled nasal nitric oxide during humming: potential clinical tool in sinonasal disease?Mauro Maniscalco, Girolamo Pelaia, Matteo Sofia
Nature Reviews. Drug Discovery|December 1, 2012
The potential of biologics for the treatment of asthmaGirolamo Pelaia, Alessandro Vatrella, Rosario Maselli
Multidisciplinary Respiratory Medicine|February 21, 2015
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrroniumGirolamo Pelaia, Rosario Maselli, Luca Gallelli
Pharmacology|December 5, 2014
Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol/glycopyrroniumGirolamo Pelaia, Rosario Maselli, Maria Gabriella Matera
Proteomics. Clinical Applications|December 16, 2014
Asthma and COPD proteomics: current approaches and future directionsRosa Terracciano, Girolamo Pelaia, Mariaimmacolata Preianò, et al.
Respiratory Medicine|July 9, 2022
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemicVincenzo Patella, Corrado Pelaia, Roberta Zunno, et al.
Drug Design, Development and Therapy|April 3, 2018
Benralizumab in the treatment of severe asthma: design, development and potential place in therapyCorrado Pelaia, Alessandro Vatrella, Andrea Bruni, et al.
Expert Review of Respiratory Medicine|February 21, 2020
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectivesCorrado Pelaia, Alessandro Vatrella, Angela Sciacqua, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2005
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthmaAlessandro Vatrella, Antonio Ponticiello, Girolamo Pelaia, et al.
Journal of Asthma and Allergy|September 13, 2014
Dupilumab: a novel treatment for asthmaAlessandro Vatrella, Immacolata Fabozzi, Cecilia Calabrese, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Biomarkers in Medicine|April 4, 2013
Exhaled nasal nitric oxide during humming: potential clinical tool in sinonasal disease?Mauro Maniscalco, Girolamo Pelaia, Matteo Sofia
Nature Reviews. Drug Discovery|December 1, 2012
The potential of biologics for the treatment of asthmaGirolamo Pelaia, Alessandro Vatrella, Rosario Maselli
Multidisciplinary Respiratory Medicine|February 21, 2015
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrroniumGirolamo Pelaia, Rosario Maselli, Luca Gallelli
Pharmacology|December 5, 2014
Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol/glycopyrroniumGirolamo Pelaia, Rosario Maselli, Maria Gabriella Matera
Proteomics. Clinical Applications|December 16, 2014
Asthma and COPD proteomics: current approaches and future directionsRosa Terracciano, Girolamo Pelaia, Mariaimmacolata Preianò, et al.
Respiratory Medicine|July 9, 2022
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemicVincenzo Patella, Corrado Pelaia, Roberta Zunno, et al.
Drug Design, Development and Therapy|April 3, 2018
Benralizumab in the treatment of severe asthma: design, development and potential place in therapyCorrado Pelaia, Alessandro Vatrella, Andrea Bruni, et al.
Expert Review of Respiratory Medicine|February 21, 2020
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectivesCorrado Pelaia, Alessandro Vatrella, Angela Sciacqua, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2005
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthmaAlessandro Vatrella, Antonio Ponticiello, Girolamo Pelaia, et al.
Journal of Asthma and Allergy|September 13, 2014
Dupilumab: a novel treatment for asthmaAlessandro Vatrella, Immacolata Fabozzi, Cecilia Calabrese, et al.
Pageof 16